The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish

PLoS Currents

Volumn , Issue , 2011, Pages

  Lipscomb, Leanne ^a   Angela Parkin, Caroline ^a   Juusola, Mikko ^a   Winder, Steve J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; MUSCULAR DYSTROPHY; NONHUMAN; PHENOTYPE; QUANTITATIVE ANALYSIS; TISSUE STRUCTURE; ZEBRA FISH; ALLELE; BIREFRINGENCE; CELL STRUCTURE; DOSE RESPONSE; FOURIER ANALYSIS; HETEROZYGOTE; HOMOZYGOTE; MUSCLE CELL;

EID: 84867443849     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1286     Document Type: Article

References (21)

1. Rubinstein A (2003) Zebrafish: from disease modeling to drug discovery. Curr Opin Drug Discov Devel 6: 218-223.
2. den Hertog J (2005) Chemical genetics: Drug screens in Zebrafish. Biosci Rep 25: 289-297.
3. Chakraborty C, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G (2009) Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab. 10: 116-124
4. Guyon JR, Steffen LS, Howell MH, Pusack TJ, Lawrence C, et al. (2007) Modeling human muscle disease in zebrafish. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1772: 205-215.
5. Bassett DI, Currie PD (2003) The zebrafish as a model for muscular dystrophy and congenital myopathy. Hum Mol Genet 12: R265-270.
6. Bassett DI, Bryson-Richardson RJ, Daggett DF, Gautier P, Keenan DG, et al. (2003) Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development 130: 5851-5860.
7. Guyon JR, Mosley AN, Zhou Y, O'Brien KF, Sheng X, et al. (2003) The dystrophin associated protein complex in zebrafish. Hum Mol Genet 12: 601-615.
8. Steffen L, Guyon J, Vogel E, Beltre R, Pusack T, et al. (2007) Zebrafish orthologs of human muscular dystrophy genes. BMC Genomics 8: 79.
9. Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, et al. (2011) Drug screening in a zebrafish model of Duchenne muscular dystrophy. Proc Nat Acad Sci US 108: 5331-5336.
10. Adamo CM, Dai D-F, Percival JM, Minami E, Willis MS, et al. (2010) Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Nat Acad Sci US 107: 19079-19083.
11. Asai A, Sahani N, Kaneki M, Ouchi Y, Martyn JAJ, et al. (2007) Primary Role of Functional Ischemia, Quantitative Evidence for the Two-Hit Mechanism, and Phosphodiesterase-5 Inhibitor Therapy in Mouse Muscular Dystrophy. PLoS One 2: e806.
12. Ilsley JL, Sudol M, Winder SJ (2001) The interaction of dystrophin with b-dystroglycan is regulated by tyrosine phosphorylation. Cell Signal 13: 625-632.
13. James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JN, et al. (2000) Adhesion-dependent tyrosine phosphorylation of b-dystroglycan regulates its interaction with utrophin. J Cell Sci 113: 1717-1726.
14. Sotgia F, Bonuccelli G, Bedford M, Brancaccio A, Mayer U, et al. (2003) Localization of Phospho-bdystroglycan (pY892) to an Intracellular Vesicular Compartment in Cultured Cells and Skeletal Muscle Fibers in Vivo. Biochem 42: 7110-7123.
15. Bonuccelli G, Sotgia F, Capozza F, Gazzerro E, Minetti C, et al. (2007) Localized treatment with a novel FDAapproved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice. Cell Cycle 6: 1242-1248.
16. Gazzerro E, Assereto S, Bonetto A, Sotgia F, ScarfÏ S, et al. (2010) Therapeutic Potential of Proteasome Inhibition in Duchenne and Becker Muscular Dystrophies. Am J Pathol 176: 1863-1877.
17. Bendat JS, Piersol AG (1971) Random Data: Analysis and Measurement Procedures.: John Wiley and Sons, Inc., New York, London, Sydney, Toronto. 566 p.
18. Harris FJ (1978) On the use of the windows for harmonic analysis with the discrete Fourier transform. Proc IEEE 66: 51-84.
19. Assereto S, Stringara S, Sotgia F, Bonuccelli G, Broccolini A, et al. (2006) Pharmacological Rescue of the Dystrophin Complex in Duchenne and Becker Skeletal Muscle Explants by Proteasomal Inhibitor Treatment. Am J Physiol Cell Physiol 290: C577-582.
20. Bonuccelli G, Sotgia F, Schubert W, Park DS, Frank PG, et al. (2003) Proteasome Inhibitor (MG-132) Treatment of mdx Mice Rescues the Expression and Membrane Localization of Dystrophin and Dystrophin-Associated Proteins. Am J Pathol 163: 1663-1675.
21. Berger J, Berger S, Jacoby AS, Wilton SD, Currie PD (2011) Evaluation of Exon-Skipping Strategies for Duchenne Muscular Dystrophy Utilizing Dystrophin-deficient Zebrafish. J Cell Mol Med DOI: 10.1111/j.1582-4934.2011.01260.x.